Clover Health is trading 7.1% up at $4.82, rebounding from recent weakness despite a lack of fresh, stock-specific catalysts this morning.
- The move follows weeks of selling pressure tied to valuation concerns after a Medicare Star rating court win and subsequent insider selling.
- With broader indices trading modestly higher, the bounce appears driven by technical buying and improving sentiment rather than new fundamental events.